B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 40.99% 39.21% 27.06% -203.34% 27.89%
Total Depreciation and Amortization 67.48% 65.68% 64.96% 30.69% 0.29%
Total Amortization of Deferred Charges 19.43% 21.71% 21.61% 5.75% 0.92%
Total Other Non-Cash Items -69.94% 334.58% 218.43% 5,630.84% 289.73%
Change in Net Operating Assets 36.46% 52.66% -450.62% -137.17% -8.05%
Cash from Operations 44.61% 141.59% 16.77% 22.73% 54.80%
Capital Expenditure -0.66% -166.99% -293.79% 53.24% -99.74%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -88.27% -167.74% 100.17% -144.25% 223.30%
Cash from Investing -89.61% -173.91% 96.82% -2,616.24% 220.38%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 38.33% 304.74% -- 15.65% -11.21%
Repurchase of Common Stock -73.01% -10.31% 51.43% 100.00% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 2,723.18% -9.13% 51.43% 197.20% -220.69%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 142.27% -29.31% 190.33% -636.31% 1,166.61%